November 17, 2020
Sen. Rob Portman (R-Ohio) told CNBC on Tuesday that he enrolled in Johnson & Johnson’s COVID-19 vaccine clinical trial 12 days ago, CNBC reports.
Portman told CNBC’s “Squawk Box” that he signed up for the clinical trial because he wanted to demonstrate that vaccines are important to ending the ongoing pandemic.
“The most important thing we can do right now is get these vaccines out and on the market, and we’ve got to ensure people are actually going to get vaccinated,” the junior senator from Ohio said, on camera from Capitol Hill while wearing a mask. He also emphasized the importance of wearing masks and practicing social distancing.
“It’s one thing to have the vaccines, which I think will be ready by the end of this year, so really in just a month and a half, but we’ve got to be sure that people are willing to be vaccinated,” Portman continued. “So the reason I participated in